Wojciech Jurczak - Dept Hematol, Jagiellonian Univ

基本信息

浏览量：163

职业迁徙

个人简介

W. Jurczak currently works at Polish Naval Academy. W. Jurczak does research in Naval Engineering, Mechanical Engineering and Materials Engineering. Their current project is 'w.jurczak@amw.gdynia.pl'.

研究兴趣

论文共 640 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Safety and Efficacy of Acalabrutinib Plus Bendamustine and Rituximab in Patients with Treatment-Naive or Relapsed / Refractory Mantle Cell Lymphoma: Phase Ib Trial

Tycel Phillips,Michael Wang,Tadeusz Robak,David Gallinson,Don Stevens,Krish Patel,Safaa Ramadan,Chuan-Chuan Wun,Wojciech Jurczak,Stephen D Smith

Haematologicano. 3 (2025): 715-724

引用0浏览0WOS引用

Ibrutinib Plus Venetoclax in Relapsed or Refractory Mantle Cell Lymphoma (SYMPATICO): a Multicentre, Randomised, Double-Blind, Placebo-Controlled, Phase 3 Study

Michael Wang,Wojciech Jurczak,Marek Trneny, David Belada,Tomasz Wrobel, Nilanjan Ghosh,Mary-Margaret Keating, Tom van Meerten,Ruben Fernandez Alvarez,Gottfried von Keudell, Catherine Thieblemont, Frederic Peyrade, Marc Andre,Marc Hoffmann,Edith Szafer-Glusman,Jennifer Lin,James P Dean,Jutta K Neuenburg,Constantine S Tam

The Lancet Oncologyno. 2 (2025): 200-213

引用0浏览0WOS引用

A First-in-Human Phase 1 Study of Oral LOXO-338, a Selective BCL2 Inhibitor, in Patients with Advanced Hematologic Malignancies (trial in Progress)

Alvaro J. Alencar,Lindsey E. Roeker,Marc Hoffman,Guru Subramanian Guru Murthy,Vishalkumar Patel,Nora C. Ku,James M. Pauff,Toby A. Eyre,Wojciech Jurczak,Steven Le Gouill

Clinical Lymphoma Myeloma and Leukemia (2025)

引用4浏览0引用

A First-in-human Phase 1 Study of LOXO-338, an Oral Selective Bcl-2 Inhibitor, in Patients with Advanced Hematologic Malignancies

Michal Kwiatek,Guru Subramanian Guru Murthy, Marc Hoffmann,Benoit Tessoulin,Alexey Danilov,Alvaro J. Alencar,Nirav N. Shah,Hervé Ghesquieres, Steven Le Gouill,Wojciech Jurczak,Hongmei Han,Eunice Yuen,Vishalkumar Patel, Yingying Guo-Avrutin,James M. Pauff,Lindsey E. Roeker

Clinical Lymphoma Myeloma and Leukemia (2025)

引用0浏览0引用

A First-in-Human Phase I Study of LOXO-338, an Oral Selective Bcl-2 Inhibitor, in Patients with Advanced Hematologic Malignancies

Michal Kwiatek,Guru Subramanian Guru Murthy, Marc Hoffmann,Benoit Tessoulin,Alexey Danilov,Alvaro J Alencar,Nirav N Shah,Hervé Ghesquieres,Steven Le Gouill,Wojciech Jurczak,Hongmei Han,Eunice Yuen,Vishalkumar Patel, Yingying Guo-Avrutin,James M Pauff,Lindsey E Roeker

Clinical lymphoma, myeloma & leukemia (2025)

引用0浏览0WOS引用

Bispecific Antibodies in Relapsed/refractory Diffuse Large B-cell Lymphoma

Michał Danecki,Wojciech Jurczak

Acta Haematologica Polonica（2024）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn